Tetrahydropyran-3-yl amine hydrochloride, 95.0%, 5g

2-Ethyltoluene>99.0%(GC)5mL

(S)-2-((tert-Butoxycarbonyl)amino)-3-(2-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 1g

Dilmapimod, 99.56%, 25mg

2-BROMO-5,8-DIOXASPIRO[3.4]OCTANE, 95.0%, 500mg

Ethyl 6-oxo-6-[3-(3-pyrrolinomethyl)phenyl]hexanoate, 97.0%, 1g

(1-isopropylpiperidin-4-yl)methanol, 95.0%, 10g

oxalic acid; tert-butyl 4-hydrazinylpiperidine-1-carboxylate, 97, 1g

[4-Methyl-5-(4-piperidinyl)-4H-1,2,4-triazol-3-yl]methanol dihydrochloride hydrate, 95.0%, 1g

4',4''',4''''',4'''''''-(Ethene-1,1,2,2-tetrayl)tetrakis(([1,1'-biphenyl]-4-ol)), 97%, 1g

4-(4-Fluorophenyl)-1,2,3,6-tetrahydropyridine hydrochloride, 97%, 1g

(1R,2S,5R)-(-)-Menthyl (S)-p-Toluenesulfinate>98.0%(HPLC)25g

Potash lye 20%, 20%, pure, 1 l, plastic packaging.